Interventions that improve self-care confidence may be particularly important in older adults with moderate to advancedHF.
2
This study sought to characterize myostatin expression and activation in advancedHF before and after LVAD support.
3
We sought to determine the association between noncardiac comorbidities and HRQOL in ambulatory patients with advancedHF.
4
Conclusions: This study represents the largest report to date of women with ambulatory advancedHF receiving contemporary therapies.
5
The aim of the study is to better understand disease trajectory and optimal timing of advancedHF therapies.
6
The eNO may be an easily obtainable and quantifiable measure of the response to therapy in advancedHF.
7
Conclusions: Hormone replacement therapy is associated with a marked improvement in survival in postmenopausal women with advancedHF.
8
Lipidomic analysis revealed increased total and very long-chain ceramides in myocardium and serum of patients with advancedHF.
9
Conclusions: In chronic systolic HF, elevated plasma MPO levels are associated with an increased likelihood of more advancedHF.
10
Conclusions: Advanced care planning that seamlessly bridges hospital and home must be standard care for patients who have advancedHF.
11
Objective: To identify, from the patient's perspective, the major opportunities for improving EOL care for patients hospitalized because of advancedHF.
12
This study is designed to investigate safety and biological effects of enzyme replacement using gene transfer in patients with advancedHF.
13
Conclusions: While noncardiac comorbidities were prevalent in ambulatory advancedHF patients, only depression was associated with decreased generic and HF-specific HRQOL.
14
Conclusions: We tailored and demonstrated feasibility of providing an early, concurrent palliative care intervention to patients with advancedHF and their caregivers.
15
In conclusion, the findings demonstrate the beneficial effects of a low-level, home-based walking program on weight loss in overweight and obese patients with advancedHF.
16
UPR activation and apoptosis are reduced after mechanical unloading, which may be mediated by the improvement of Ca(2+) handling in patients with advancedHF.